
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 17.310 | 17.310 | 0.000 |
Shares | 83.490 | 83.490 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.634 | 22.347 |
Price to Book | 2.636 | 2.714 |
Price to Sales | 2.633 | 3.330 |
Price to Cash Flow | 14.430 | 16.400 |
Dividend Yield | 2.204 | 2.102 |
5 Years Earnings Growth | 4.850 | 6.822 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.180 | 97.797 |
Consumer Cyclical | 0.810 | 0.671 |
Number of long holdings: 85
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 6.42 | 301.18 | +5.31% | |
Kelun Pharm A | CNE100000PW7 | 6.17 | 38.56 | +1.61% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 5.13 | 108.76 | +1.30% | |
WuXi AppTec | CNE1000031K4 | 4.39 | 63.51 | -1.84% | |
Jiangsu Hengrui | CNE0000014W7 | 4.09 | 54.74 | +1.18% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 3.11 | 48.06 | -1.50% | |
Jiangzhong Pharm | CNE000000M80 | 2.51 | 23.06 | +0.22% | |
KPC Pharm | CNE0000015P8 | 2.38 | 15.94 | -0.44% | |
APT Medical | CNE100004C45 | 2.23 | 396.51 | -2.10% | |
Pharmaron Beijing | CNE100003JW4 | 2.03 | 23.84 | +0.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDIII | 14.08B | -7.34 | 16.26 | 16.87 | ||
GF Stable Growth Mixed Assets Fund | 11.33B | 0.68 | -0.40 | 5.79 | ||
GF Global Selction Eq QDII | 9.67B | -6.45 | 19.85 | 10.23 | ||
GF Tech Pioneer Alloc | 8.94B | -3.86 | -9.29 | - | ||
GF Small-Cap Growth Stock Fd(LOF) | 5.28B | -2.61 | -10.33 | 2.08 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review